Amgen (NASDAQ:AMGN) Earns Outperform Rating from Royal Bank of Canada
Amgen (NASDAQ:AMGN – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Royal Bank of Canada in a report issued on Friday,Benzinga reports. They currently have a $324.00 price target on the medical research company’s stock. Royal Bank of Canada’s target price points to a potential upside of 17.56% from the […]
More Stories
The Babysitter 3: Renewal Status, Release Date, Cast Members & Plot
Nine years after Netflix’s debut, the horror-comedy film The Babysitter remains one of the biggest hits. What began as a...
Original Games and Familiar Brands: Two Creative Routes in Online Casino Entertainment
A familiar film title can make a game recognisable before anyone opens it. An original character has a different task,...
Weather System Off North Carolina Could Become Nor’Easter or Tropical Storm: What to Know
By T.J. Muscaro The National Weather Service and its National Hurricane Center are tracking a storm system sitting off the...
Wall Street Review: Nasdaq Sinks 4.48 Percent as Inflation Fears Hit AI Stocks
By Panos Mourdoukoutas The Nasdaq Composite fell 4.48 percent for the week as hotter-than-expected inflation data sent Treasury yields higher...
Republican Attorney General Candidate New York, Saritha Komatireddy, Lays Out Her Vision
By Juliette Fairley Fresh off a fiery political debate last week, Republican challenger Saritha Komatireddy on Oct. 15 laid out...
Chaos and Violence Grip France as Far-Left Mobs Storm City Halls, Torch Streets
By Etienne Fauchaire PARIS—Stones and fireworks were already flying across Place de la République before Saturday’s demonstration against rising costs...